Cambridge New Therapeutics Forum (CamNTF): November Meeting – 16th Nov

CamNTF-logoAdvances in Patient Relevant In Vitro Models

Programme:

17:30 – Arrival, Registration, Tea & Coffee

18:00 – Introduction, Dr Mark Fiddock, VP and Head, Personalised Healthcare and Biomarker Laboratories, AstraZeneca

18:10 – Professor Ludovic Vallier, University of Cambridge & Wellcome Trust Sanger Institute: Human Pluripotent Stem Cells to Model and to Study Liver Disease

18:40 – Dr David Hughes, Chief Technical Officer, CN Bio Innovations: Microphysiological Systems for Drug Discovery

18:55 – Dr Rhiannon David, Senior Scientist, Drug Safety and Metabolism, AstraZeneca: Microphysiological Systems: Their Development and Application in the Pharmaceutical Industry

19:10 – Networking and Refreshments

20:00 – Meeting Close

Event details

Location: Milstein Building, Granta Park, Cambridge CB21 6GH
Time & Date: 5.30pm – 8pm, Thursday 16th November
Admission: Please register online here.